Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection

BACKGROUND: Cetuximab (chimeric monoclonal antibody to human epidermal growth factor receptor) is used to treat colorectal and head and neck cancers. Due to cross-reactivity with galactose-α-1,3-galactose (alpha-gal), it can induce hypersensitivity even at first administration. We aimed to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Kyung Hee, Lee, Jongsun, Beom, Seung Hoon, Shin, Sang Joon, Ahn, Joong Bae, Kim, Sung-Ryeol, Lee, Jae-Hyun, Park, Jung-Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243130/
https://www.ncbi.nlm.nih.gov/pubmed/34257795
http://dx.doi.org/10.1016/j.waojou.2021.100553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243130/
https://www.ncbi.nlm.nih.gov/pubmed/34257795
http://dx.doi.org/10.1016/j.waojou.2021.100553

Ejemplares similares